{
    "SPADE_UN_25005": {
        "Sequence Information": {
            "Peptide Name": "Cilengitide",
            "Sequence": "RGDFX",
            "Sequence Length": 5,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Membrane Protein",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Design and synthesis of novel dual-cyclic RGD peptides for αvβ3 integrin targeting.",
                    "Pubmed ID": "30732943",
                    "Reference": "Bioorg Med Chem Lett. 2019;29:896-900",
                    "Author": "Liu J, Cheng X, Tian X, Guan D, Ao J, Wu Z, Huang W, Le Z",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30732943"
                },
                {
                    "Title": "New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation.",
                    "Pubmed ID": "28351594",
                    "Reference": "Bioorg Med Chem Lett. 2017;27:1911-1913",
                    "Author": "Wu Z, Cheng X, Hong H, Zhao X, Zhou Z",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28351594"
                }
            ],
            "SPADE ID": "SPADE_UN_25005",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05302",
                    "Similarity": 1.0,
                    "Sequence": "LDDDDDINDSSNWIKANPNLGVSINLDEMKEEWEKAKRTPAERGDFITKRFNIFANNDEMSFIDYPTLQKK"
                },
                {
                    "SPADE_ID": "SPADE_N_07334",
                    "Similarity": 1.0,
                    "Sequence": "KKKKKKNKKLQQRGD"
                },
                {
                    "SPADE_ID": "SPADE_N_13003",
                    "Similarity": 1.0,
                    "Sequence": "GRGDFINLKKLAKLKKIL"
                }
            ],
            "Hemolytic Activity": "Human embryonic kidney HEK293 cells:IC50=0.22 µM",
            "Target Organism": "Human ovarian adenocarcinoma SK-OV-3(IC50=0.23±0.01µM),Human colon adenocarcinoma HT29(IC50=0.12µM)"
        }
    }
}